Skip to main content

Sialorrhea

  • Chapter
  • First Online:

Abstract

Key Points

  1. 1.

    Sialorrhea is a common condition affecting both children and adults with neuromuscular disorders including cerebral palsy, Parkinson’s disease, amyotrophic lateral sclerosis, and other neurodegenerative disorders.

  2. 2.

    Sialorrhea is a highly distressing problem that can lead to significant psychological, social, and medical issues.

  3. 3.

    A multidisciplinary approach involving speech therapy, neurology, otolaryngology, and others is advisable to help with the complex decision-making process.

  4. 4.

    In most cases, noninvasive therapeutic modalities such as physiotherapy and systemic medication should be explored prior to more invasive therapies such as the injection of botulinum toxin and surgery.

  5. 5.

    There is no consensus as to the best surgical procedure to treat sialorrhea. Procedure selection should be guided by patient characteristics including severity of drooling, presence of aspiration, and overall medical condition. It is imperative to give patients and their families clear expectations of treatment.

This is a preview of subscription content, log in via an institution.

References

  1. Erasmus CE, Van Hulst K, Rotteveel LJ, et al. Drooling in cerebral palsy: hypersalivation or dysfunctional oral motor control? Dev Med Child Neurol. 2009;51:454–9.

    Article  PubMed  Google Scholar 

  2. Holsinger FC, Bui DT. Anatomy, function, and evaluation of the salivary glands. In: Myers EN, Ferris RL, editors. Salivary gland disorders. Berlin: Springer; 2007. p. 1–16.

    Google Scholar 

  3. Volonte MA, Porta M, Comi G. Clinical assessment of dysphagia in early phases of Parkinson’s disease. Neurol Sci. 2002;23(Suppl 2):S121–2.

    Article  PubMed  Google Scholar 

  4. Tahmassebi JF, Curzon MEJ. The cause of drooling in children with cerebral palsy—hypersalivation or swallowing defect? Int J Paediatr Dent. 2003;13:106–11.

    Article  CAS  PubMed  Google Scholar 

  5. Hamdy S, Aziz Q, Rothwell JC, Hobson A, Barlow J, Thompson DG. Cranial nerve modulation of human cortical swallowing motor pathways. Am J Physiol. 1997;272:G802–8.

    CAS  PubMed  Google Scholar 

  6. van der Burg JJ, Jongerius PH, van Limbeek J, van Hulst K, Rotteveel JJ. Social interaction and self-esteem of children with cerebral palsy after treatment for severe drooling. Eur J Pediatr. 2006;165:37–41.

    Article  PubMed  Google Scholar 

  7. Van der Burg JJ, Jongerius PH, Van Hulst K, Van Limbeek J, Rotteveel JJ. Drooling in children with cerebral palsy: effect of salivary flow reduction on daily life and care. Dev Med Child Neurol. 2006;48:103–7.

    Article  PubMed  Google Scholar 

  8. Miranda-Rius J, Brunet-Llobet L, Lahor-Soler E, Farré M. Salivary secretory disorders, inducing drugs, and clinical management. Int J Med Sci. 2015;12:811–24.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Ekedahl C, Hallen O. Quantitative measurement of drooling. Acta Otolaryngol. 1973;75:464–9.

    Article  CAS  PubMed  Google Scholar 

  10. Sochaniwskyj AE. Drool quantification: noninvasive technique. Arch Phys Med Rehabil. 1982;63:605–7.

    CAS  PubMed  Google Scholar 

  11. Reid SM, Johnson HM, Reddihough DS. The drooling impact scale: a measure of the impact of drooling in children with developmental disabilities. Dev Med Child Neurol. 2010;52:e23–8.

    Article  PubMed  Google Scholar 

  12. Reddihough D, Johnson H, Ferguson E. The role of a saliva control clinic in the management of drooling. J Paediatr Child Health. 1992;28:395–7.

    Article  CAS  PubMed  Google Scholar 

  13. Rapp D. Management of drooling. Dev Med Child Neurol. 1988;30:128–9.

    Article  CAS  PubMed  Google Scholar 

  14. van Hulst K, Lindeboom R, van der Burg J, Jongerius P. Accurate assessment of drooling severity with the 5-minute drooling quotient in children with developmental disabilities. Dev Med Child Neurol. 2012;54:1121–6.

    Article  PubMed  Google Scholar 

  15. Blasco PA. Management of drooling: 10 years after the consortium on drooling, 1990. Dev Med Child Neurol. 2002;44:778–81.

    Article  PubMed  Google Scholar 

  16. Thomas-Stonell N, Greenberg J. Three treatment approaches and clinical factors in the reduction of drooling. Dysphagia. 1988;3:73–8.

    Article  CAS  PubMed  Google Scholar 

  17. Heine RG, Catto-Smith AG, Reddihough DS. Effect of antireflux medication on salivary drooling in children with cerebral palsy. Dev Med Child Neurol. 1996;38:1030–6.

    Article  CAS  PubMed  Google Scholar 

  18. Camp-Bruno JA, Winsberg BG, Green-Parsons AR, Abrams JP. Efficacy of benztropine therapy for drooling. Dev Med Child Neurol. 1989;31:309–19.

    Article  CAS  PubMed  Google Scholar 

  19. Rashnoo P, Daniel SJ. Drooling quantification: correlation of different techniques. Int J Pediatr Otorhinolaryngol. 2015;79:1201–5.

    Article  PubMed  Google Scholar 

  20. Harris MM, Dignam PF. A non-surgical method of reducing drooling in cerebral-palsied children. Dev Med Child Neurol. 1980;22:293–9.

    Article  CAS  PubMed  Google Scholar 

  21. Arvedson JC, Brodsky L. Pediatric swallowing and feeding. San Diego: Singular Publishing Group; 1993.

    Google Scholar 

  22. Hyson HC, Johnson AM, Jog MS. Sublingual atropine for sialorrhea secondary to parkinsonism: a pilot study. Mov Disord. 2002;17:1318–20.

    Article  PubMed  Google Scholar 

  23. Comley C, Galletly C, Ash D. Use of atropine eye drops for clozapine induced hypersalivation. Aust N Z J Psychiatry. 2000;34:1033–4.

    Article  CAS  PubMed  Google Scholar 

  24. Mirakhur RK, Dundee JW. Comparison of the effects of atropine and glycopyrrolate on various end-organs. J R Soc Med. 1980;73:727–30.

    CAS  PubMed  PubMed Central  Google Scholar 

  25. Eiland LS. Glycopyrrolate for chronic drooling in children. Clin Ther. 2012;34:735–42.

    Article  CAS  PubMed  Google Scholar 

  26. Mier RJ, Bachrach SJ, Lakin RC, Barker T, Childs J, Moran M. Treatment of sialorrhea with glycopyrrolate: a double-blind, dose-ranging study. Arch Pediatr Adolesc Med. 2000;154:1214–8.

    Article  CAS  PubMed  Google Scholar 

  27. Zeller RS, Lee HM, Cavanaugh PF, Davidson J. Randomized phase III evaluation of the efficacy and safety of a novel glycopyrrolate oral solution for the management of chronic severe drooling in children with cerebral palsy or other neurologic conditions. Ther Clin Risk Manag. 2012;8:15–23.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Lim M, Mace A, Nouraei SA, Sandhu G. Botulinum toxin in the management of sialorrhoea: a systematic review. Clin Otolaryngol. 2006;31:267–72.

    Article  CAS  PubMed  Google Scholar 

  29. Lakraj AA, Moghimi N, Jabbari B. Sialorrhea: anatomy, pathophysiology and treatment with emphasis on the role of botulinum toxins. Toxins. 2013;5:1010–31.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Bushara KO. Sialorrhea in amyotrophic lateral sclerosis: a hypothesis of a new treatment—botulinum toxin a injections of the parotid glands. Med Hypotheses. 1997;48:337–9.

    Article  CAS  PubMed  Google Scholar 

  31. Petracca M, Guidubaldi A, Ricciardi L, et al. Botulinum toxin a and B in sialorrhea: long-term data and literature overview. Toxicon. 2015;107:129–40.

    Article  CAS  PubMed  Google Scholar 

  32. Daniel SJ. Multidisciplinary management of sialorrhea in children. Laryngoscope. 2012;122(Suppl 4):S67–8.

    Article  PubMed  Google Scholar 

  33. Suskind DL, Tilton A. Clinical study of botulinum—a toxin in the treatment of sialorrhea in children with cerebral palsy. Laryngoscope. 2002;112:73–81.

    Article  CAS  PubMed  Google Scholar 

  34. Jeung IS, Lee S, Kim HS, Yeo CK. Effect of botulinum toxin a injection into the salivary glands for sialorrhea in children with neurologic disorders. Ann Rehabil Med. 2012;36:340–6.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Khan WU, Campisi P, Nadarajah S, et al. Botulinum toxin a for treatment of sialorrhea in children: an effective, minimally invasive approach. Arch Otolaryngol Head Neck Surg. 2011;137:339–44.

    Article  PubMed  Google Scholar 

  36. Reed J, Mans CK, Brietzke SE. Surgical management of drooling: a meta-analysis. Arch Otolaryngol Head Neck Surg. 2009;135:924–31.

    Article  PubMed  Google Scholar 

  37. Wilkie TF. The problem of drooling in cerebral palsy: a surgical approach. Can J Surg. 1967;10:60–7.

    CAS  PubMed  Google Scholar 

  38. Wilkie TF, Brody GS. The surgical treatment of drooling. A ten-year review. Plast Reconstr Surg. 1977;59:791–7.

    Article  CAS  PubMed  Google Scholar 

  39. Faggella RM, Jr., Osborn JM. Surgical correction of drool: a comparison of three groups of patients. Plast Reconstr Surg 1983; 72:478-483.

    Google Scholar 

  40. Becmeur F, Schneider A, Flaum V, Klipfel C, Pierrel C, Lacreuse I. Which surgery for drooling in patients with cerebral palsy? J Pediatr Surg. 2013;48:2171–4.

    Article  PubMed  Google Scholar 

  41. De M, Adair R, Golchin K, Cinnamond MJ. Outcomes of submandibular duct relocation: a 15-year experience. J Laryngol Otol. 2003;117:821–3.

    PubMed  Google Scholar 

  42. Ekedahl C. Surgical treatment of drooling. Acta Otolaryngol. 1974;77:215–20.

    Article  CAS  PubMed  Google Scholar 

  43. Crysdale WS, White A. Submandibular duct relocation for drooling: a 10-year experience with 194 patients. Otolaryngol Head Neck Surg. 1989;101:87–92.

    Article  CAS  PubMed  Google Scholar 

  44. Greensmith AL, Johnstone BR, Reid SM, Hazard CJ, Johnson HM, Reddihough DS. Prospective analysis of the outcome of surgical management of drooling in the pediatric population: a 10-year experience. Plast Reconstr Surg. 2005;116:1233–42.

    Article  CAS  PubMed  Google Scholar 

  45. McAloney N, Kerawala CJ, Stassen LF. Management of drooling by transposition of the submandibular ducts and excision of the sublingual glands. J Ir Dent Assoc. 2005;51:126–31.

    CAS  PubMed  Google Scholar 

  46. Hornibrook J, Cochrane N. Contemporary surgical management of severe sialorrhea in children. ISRN Pediatr. 2012;2012:364875.

    Article  PubMed  PubMed Central  Google Scholar 

  47. Klem C, Mair EA. Four-duct ligation: a simple and effective treatment for chronic aspiration from sialorrhea. Arch Otolaryngol Head Neck Surg. 1999;125:796–800.

    Article  CAS  PubMed  Google Scholar 

  48. Shirley WP, Hill JS, Woolley AL, Wiatrak BJ. Success and complications of four-duct ligation for sialorrhea. Int J Pediatr Otorhinolaryngol. 2003;67:1–6.

    Article  PubMed  Google Scholar 

  49. Martin TJ, Conley SF. Long-term efficacy of intra-oral surgery for sialorrhea. Otolaryngol Head Neck Surg. 2007;137:54–8.

    Article  PubMed  Google Scholar 

  50. Chanu NP, Sahni JK, Aneja S, Naglot S. Four-duct ligation in children with drooling. Am J Otolaryngol. 2012;33:604–7.

    Article  PubMed  Google Scholar 

  51. Khan WU, Islam A, Fu A, et al. Four-duct ligation for the treatment of Sialorrhea in children. JAMA Otolaryngol Head Neck Surg. 2016;

    Google Scholar 

  52. Grewal DS, Hiranandani NL, Rangwalla ZA, Sheode JH. Transtympanic neurectomies for control of drooling. Auris Nasus Larynx. 1984;11:109–14.

    Article  CAS  PubMed  Google Scholar 

  53. Mullins WM, Gross CW, Moore JM. Long-term follow-up of tympanic neurectomy for sialorrhea. Laryngoscope. 1979;89:1219–23.

    Article  CAS  PubMed  Google Scholar 

  54. Grant R, Miller S, Simpson D, Lamey PJ, Bone I. The effect of chorda tympani section on ipsilateral and contralateral salivary secretion and taste in man. J Neurol Neurosurg Psychiatry. 1989;52:1058–62.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  55. Parisier SC, Blitzer A, Binder WJ, Friedman WF, Marovitz WF. Tympanic neurectomy and chorda tympanectomy for the control of drooling. Arch Otolaryngol. 1978;104:273–7.

    Article  CAS  PubMed  Google Scholar 

  56. Spock T, Hoffman HT, Joshi AS. Transoral submandibular ganglion neurectomy: an anatomical feasibility study. Ann Otol Rhinol Laryngol. 2015;124:341–4.

    Article  PubMed  Google Scholar 

  57. Borg M, Hirst F. The role of radiation therapy in the management of sialorrhea. Int J Radiat Oncol Biol Phys. 1998;41:1113–9.

    Article  CAS  PubMed  Google Scholar 

  58. Neppelberg E, Haugen DF, Thorsen L, Tysnes OB. Radiotherapy reduces sialorrhea in amyotrophic lateral sclerosis. Eur J Neurol. 2007;14:1373–7.

    Article  CAS  PubMed  Google Scholar 

  59. Bourry N, Guy N, Achard JL, Verrelle P, Clavelou P, Lapeyre M. Salivary glands radiotherapy to reduce sialorrhea in amyotrophic lateral sclerosis: dose and energy. Cancer Radiother. 2013;17:191–5.

    Article  CAS  PubMed  Google Scholar 

  60. Guy N, Bourry N, Dallel R, et al. Comparison of radiotherapy types in the treatment of sialorrhea in amyotrophic lateral sclerosis. J Palliat Med. 2011;14:391–5.

    Article  PubMed  Google Scholar 

  61. Assouline A, Levy A, Abdelnour-Mallet M, et al. Radiation therapy for hypersalivation: a prospective study in 50 amyotrophic lateral sclerosis patients. Int J Radiat Oncol Biol Phys. 2014;88:589–95.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kirk Withrow M.D. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG

About this chapter

Cite this chapter

Withrow, K., Chung, T. (2018). Sialorrhea. In: Gillespie, M., Walvekar, R., Schaitkin, B., Eisele, D. (eds) Gland-Preserving Salivary Surgery. Springer, Cham. https://doi.org/10.1007/978-3-319-58335-8_17

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-58335-8_17

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-58333-4

  • Online ISBN: 978-3-319-58335-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics